Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael Bartholomew
AddedMar 31, 2024
UpdatedMay 31, 2026
Michael Bartholomew

Michael Bartholomew

Board Member, Achelios Therapeutics

CrunchbaseLinkedIn

Michael Bartholomew's Career

Achelios Therapeutics
Achelios Therapeutics

Chapel Hill, NC, US

Board Member· Board
Otomagnetics
Otomagnetics

Bethesda, MD, US

Board Member· Board
Neuro42
Neuro42

Oakland, CA, US

Co-Founder
Promaxo
Promaxo

Oakland, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael Bartholomew's Career

Achelios Therapeutics
Achelios Therapeutics
Angel$3.5M52012Chapel Hill, NC, US
Board Member· Board

Leadership at Achelios Therapeutics

Crist FrangakisCrist FrangakisFounder & CEO

Similar to Achelios Therapeutics

AkelosAkelosNew York City, NY, USDrug Developmentest. 2018AkelosNew York City, NY, US · est. 2018

Akelos, a NY-based biopharmaceutical company, develops innovative non-opioid drugs for neuropathic pain treatment.

Seed · $2.1M5
Exodos Life SciencesExodos Life SciencesPrinceton, NJ, USPharmaceuticalsest. 2009Exodos Life SciencesPrinceton, NJ, US · est. 2009

Exodos Life Sciences: Developing innovative pharmaceutical products since 2009, based in North Carolina.

Pre-Seed · $2.4M5
Isosceles PharmaceuticalsIsosceles PharmaceuticalsWilmington, NC, USPain Managementest. 2019Isosceles PharmaceuticalsWilmington, NC, US · est. 2019

Isosceles Pharmaceuticals: A preclinical biotech firm developing safe, acute pain management solutions.

Series A · $5M8
Concentric AnalgesicsConcentric AnalgesicsSan Francisco, CA, USTherapeuticsest. 2014Concentric AnalgesicsSan Francisco, CA, US · est. 2014

Concentric Analgesics, Inc.: A biotech firm innovating non-opioid solutions for acute and chronic pain.

Series B · $103.1M22
Otomagnetics
Otomagnetics
Series A$2.4M112012Bethesda, MD, US
Board Member· Board

Leadership at Otomagnetics

Benjamin ShapiroBenjamin ShapiroCo-Founder
David BeylinDavid BeylinCo-Founder
Neuro42
Neuro42
Series B$12.8M262020Oakland, CA, US
Co-Founder

Leadership at Neuro42

Abhita VohraAbhita VohraCo-Founder
Amit VohraAmit VohraCo-Founder & CEO
Dinesh K.Dinesh K.Co-Founder

Similar to Neuro42

BrainHealthBrainHealthDunedin, FL, USMedical Equipmentest. 2015BrainHealthDunedin, FL, US · est. 2015

BrainHealth: Innovating and supplying advanced neurological medical equipment.

Series C · $465M75
NeuroFieldzNeuroFieldzNewton, MA, USMedical Devicesest. 2013NeuroFieldzNewton, MA, US · est. 2013

NeuroFieldz: Innovating brain health tech for early detection of cerebral disorders.

Angel · $150k1
Alpha-MriAlpha-MriMenlo Park, CA, USMedical Imagingest. 2014Alpha-MriMenlo Park, CA, US · est. 2014

Innovating MRI tech since 2014 in stealth mode.

Series A · $1.3M50
SpinTechSpinTechBingham Farms, MI, USMedical Softwareest. 2017SpinTechBingham Farms, MI, US · est. 2017

SpinTech, Inc.: Pioneering MRI software for precise diagnosis and treatment of neurological conditions.

Series A · $6.5M24
Promaxo
Promaxo
Series B$28.8M892016Oakland, CA, US
Co-Founder

Leadership at Promaxo

Kamal PatelKamal PatelBoard Member

Similar to Promaxo

PMXPMXPalatine, IL, USHealth Insightsest. 2020PMXPalatine, IL, US · est. 2020

PMX, a medical tech firm, uses AI to deliver personalized health insights via an automated imaging platform for universal care.

Series A · $100k6
PromedixPromedixPortland, OR, USMedical Devicesest. 2019PromedixPortland, OR, US · est. 2019

Promedix: Innovating home patient monitoring with medical devices for trauma, dehydration, and sepsis care.

Angel · $350k5
Neuro42Neuro42Oakland, CA, USMedical Devicesest. 2020Neuro42Oakland, CA, US · est. 2020

neuro42: Innovating advanced MRI tech for diagnosing and treating neurological conditions.

Series B · $12.8M26
Smart Choice MRISmart Choice MRIMequon, WI, USMRI Servicesest. 2006Smart Choice MRIMequon, WI, US · est. 2006

Smart Choice MRI, LLC provides affordable, transparently priced MRI services across the US.

Series A · $13.5M30

Michael Bartholomew's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Michael Bartholomew

Nicole VitulloNicole VitulloBoard Member · BioScience ManagersAdrian AdamsAdrian AdamsBoard Member · AcelRx PharmaceuticalsRonald LennoxRonald LennoxBoard Member · BiorelixMichael YangMichael YangBoard Member · Kiwi CrateSeth FischerSeth FischerBoard Member · Agile TherapeuticsMichael D EhlersMichael D EhlersFounder · Intergalactic Therapeutics